Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform. (2022)
Attributed to:
Novel methods in data science to quantify viral and environmental triggers of chronic disease exacerbations
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2665-9913(22)00098-4
PubMed Identifier: 35698725
Publication URI: http://europepmc.org/abstract/MED/35698725
Type: Journal Article/Review
Volume: 4
Parent Publication: The Lancet. Rheumatology
Issue: 7
ISSN: 2665-9913